Human Albumin Injection - Global and China Top Players Market Share and Ranking 2023
According to the research report, the global market for Human Albumin Injection should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Human Albumin Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Human Albumin Injection market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Human albumin solutions are used in a range of medical and surgical problems.
This report studies and analyses global Human Albumin Injection status and future trends, helps the client to determine the Human Albumin Injection market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Albumin Injection, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Report Highlights
(1) Global Human Albumin Injection market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Human Albumin Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Human Albumin Injection sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Human Albumin Injection key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Human Albumin Injection key producing regions, capacity, production, and year over year growth
(6) Human Albumin Injection industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Market segment by Type, covers
Blood Extraction
Recombine
Market segment by Application, can be divided into
Hospital
Clinic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Key Findings from The Report:
Chapter 1: to describe Human Albumin Injection product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Albumin Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Human Albumin Injection market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Human Albumin Injection, percent & CAGR, 2018-2029
Chapter 5: Human Albumin Injection industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Human Albumin Injection Definition
1.2 Global Human Albumin Injection Market Size and Forecast
1.2.1 By Consumption Value, Global Human Albumin Injection Market Size，2018-2029
1.2.2 By Sales Quantity, Global Human Albumin Injection Market Size，2018-2029
1.2.3 Global Human Albumin Injection Average Selling Price (ASP)，2018-2029
1.3 China Human Albumin Injection Market Size and Forecast
1.3.1 By Consumption Value, China Human Albumin Injection Market Size，2018-2029
1.3.2 By Sales Quantity, China Human Albumin Injection Market Size，2018-2029
1.3.3 China Human Albumin Injection Average Selling Price (ASP)， 2018-2029
1.4 Share of China Human Albumin Injection Market with Respect to the Global Market
1.4.1 By Consumption Value, China Human Albumin Injection Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Human Albumin Injection Market Share in Global, 2018-2029
1.4.3 Human Albumin Injection Market Size: China VS Global, 2018-2029
1.5 Human Albumin Injection Market Dynamics
1.5.1 Human Albumin Injection Market Drivers
1.5.2 Human Albumin Injection Market Restraints
1.5.3 Human Albumin Injection Industry Trends
1.5.4 Human Albumin Injection Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Human Albumin Injection, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Human Albumin Injection, Global Market Share by Company, 2018-2023
2.3 Human Albumin Injection Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Human Albumin Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Albumin Injection Concentration Ratio
2.6 Global Human Albumin Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Human Albumin Injection Manufacturers Product Type
2.8 Head Office and Human Albumin Injection Production Site of Key Manufacturer
2.9 Human Albumin Injection Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Human Albumin Injection, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Human Albumin Injection, China Market Share by Company, 2018-2023
3.3 China Human Albumin Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Human Albumin Injection Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Human Albumin Injection Capacity by Region
4.3 Global Human Albumin Injection Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Human Albumin Injection Production by Region, 2018-2029
4.5 Global Human Albumin Injection Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Albumin Injection Industry Chain
5.2 Human Albumin Injection Upstream Analysis
5.2.1 Human Albumin Injection Core Raw Materials
5.2.2 Main Manufacturers of Human Albumin Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Albumin Injection Production Mode
5.6 Human Albumin Injection Procurement Model
5.7 Human Albumin Injection Industry Sales Model and Sales Channels
5.7.1 Human Albumin Injection Sales Model
5.7.2 Human Albumin Injection Typical Distributors
6 Sights by Type
6.1 Human Albumin Injection Classification
6.1.1 Blood Extraction
6.1.2 Recombine
6.2 By Type, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Albumin Injection Consumption Value, 2018-2029
6.4 By Type, Global Human Albumin Injection Sales Quantity, 2018-2029
6.5 By Type, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Human Albumin Injection Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.2 By Application, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Albumin Injection Consumption Value, 2018-2029
7.4 By Application, Global Human Albumin Injection Sales Quantity, 2018-2029
7.5 By Application, Global Human Albumin Injection Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Albumin Injection Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Albumin Injection Consumption Value, 2018-2029
8.3 By Region, Global Human Albumin Injection Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Human Albumin Injection & Forecasts, 2018-2029
8.4.2 By Country, North America Human Albumin Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Human Albumin Injection Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Albumin Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Albumin Injection Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Albumin Injection Market Size Market Share
8.7 South America
8.7.1 South America Human Albumin Injection Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Albumin Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Albumin Injection Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Human Albumin Injection Consumption Value, 2018-2029
9.3 By Country, Global Human Albumin Injection Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Albumin Injection Market Size, 2018-2029
9.4.2 By Type, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Albumin Injection Market Size, 2018-2029
9.5.2 By Type, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Human Albumin Injection Market Size, 2018-2029
9.6.2 By Type, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Albumin Injection Market Size, 2018-2029
9.7.2 By Type, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Albumin Injection Market Size, 2018-2029
9.8.2 By Type, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Albumin Injection Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Human Albumin Injection Market Size, 2018-2029
9.10.2 By Type, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Human Albumin Injection Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Octapharma
10.1.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
10.1.2 Octapharma Human Albumin Injection Models, Specifications, and Application
10.1.3 Octapharma Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Octapharma Company Profile and Main Business
10.1.5 Octapharma Recent Developments
10.2 CSL Behring
10.2.1 CSL Behring Company Information, Head Office, Market Area, and Industry Position
10.2.2 CSL Behring Human Albumin Injection Models, Specifications, and Application
10.2.3 CSL Behring Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 CSL Behring Company Profile and Main Business
10.2.5 CSL Behring Recent Developments
10.3 Biotest (UK) Ltd
10.3.1 Biotest (UK) Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 Biotest (UK) Ltd Human Albumin Injection Models, Specifications, and Application
10.3.3 Biotest (UK) Ltd Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Biotest (UK) Ltd Company Profile and Main Business
10.3.5 Biotest (UK) Ltd Recent Developments
10.4 Baxter
10.4.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.4.2 Baxter Human Albumin Injection Models, Specifications, and Application
10.4.3 Baxter Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Baxter Company Profile and Main Business
10.4.5 Baxter Recent Developments
10.5 Kedrion Biopharma, Inc.
10.5.1 Kedrion Biopharma, Inc. Company Information, Head Office, Market Area, and Industry Position
10.5.2 Kedrion Biopharma, Inc. Human Albumin Injection Models, Specifications, and Application
10.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Kedrion Biopharma, Inc. Company Profile and Main Business
10.5.5 Kedrion Biopharma, Inc. Recent Developments
10.6 Grifols
10.6.1 Grifols Company Information, Head Office, Market Area, and Industry Position
10.6.2 Grifols Human Albumin Injection Models, Specifications, and Application
10.6.3 Grifols Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Grifols Company Profile and Main Business
10.6.5 Grifols Recent Developments
10.7 GE HealthCare
10.7.1 GE HealthCare Company Information, Head Office, Market Area, and Industry Position
10.7.2 GE HealthCare Human Albumin Injection Models, Specifications, and Application
10.7.3 GE HealthCare Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 GE HealthCare Company Profile and Main Business
10.7.5 GE HealthCare Recent Developments
10.8 Bio Products Laboratory
10.8.1 Bio Products Laboratory Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bio Products Laboratory Human Albumin Injection Models, Specifications, and Application
10.8.3 Bio Products Laboratory Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bio Products Laboratory Company Profile and Main Business
10.8.5 Bio Products Laboratory Recent Developments
10.9 Green Cross
10.9.1 Green Cross Company Information, Head Office, Market Area, and Industry Position
10.9.2 Green Cross Human Albumin Injection Models, Specifications, and Application
10.9.3 Green Cross Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Green Cross Company Profile and Main Business
10.9.5 Green Cross Recent Developments
10.10 SK Plasma
10.10.1 SK Plasma Company Information, Head Office, Market Area, and Industry Position
10.10.2 SK Plasma Human Albumin Injection Models, Specifications, and Application
10.10.3 SK Plasma Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 SK Plasma Company Profile and Main Business
10.10.5 SK Plasma Recent Developments
10.11 Instituto Grifols
10.11.1 Instituto Grifols Company Information, Head Office, Market Area, and Industry Position
10.11.2 Instituto Grifols Human Albumin Injection Models, Specifications, and Application
10.11.3 Instituto Grifols Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Instituto Grifols Company Profile and Main Business
10.11.5 Instituto Grifols Recent Developments
10.12 Takeda
10.12.1 Takeda Company Information, Head Office, Market Area, and Industry Position
10.12.2 Takeda Human Albumin Injection Models, Specifications, and Application
10.12.3 Takeda Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Takeda Company Profile and Main Business
10.12.5 Takeda Recent Developments
10.13 Hualan Bio
10.13.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
10.13.2 Hualan Bio Human Albumin Injection Models, Specifications, and Application
10.13.3 Hualan Bio Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Hualan Bio Company Profile and Main Business
10.13.5 Hualan Bio Recent Developments
10.14 Nanyue Biopharmaceuticals
10.14.1 Nanyue Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.14.2 Nanyue Biopharmaceuticals Human Albumin Injection Models, Specifications, and Application
10.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Nanyue Biopharmaceuticals Company Profile and Main Business
10.14.5 Nanyue Biopharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Human Albumin Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Albumin Injection Market Restraints
Table 3. Human Albumin Injection Market Trends
Table 4. Human Albumin Injection Industry Policy
Table 5. Global Human Albumin Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Albumin Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Albumin Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Human Albumin Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Human Albumin Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Human Albumin Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Albumin Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Albumin Injection Manufacturers Product Type
Table 13. Head Office and Human Albumin Injection Production Site of Key Manufacturer
Table 14. Human Albumin Injection Capacity of Major Manufacturers and Future Plan
Table 15. China Human Albumin Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Human Albumin Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Human Albumin Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Human Albumin Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Human Albumin Injection Production by Region, 2018-2023, (K Units)
Table 20. Global Human Albumin Injection Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Human Albumin Injection Upstream (Raw Materials)
Table 22. Global Human Albumin Injection Typical Customers
Table 23. Human Albumin Injection Typical Distributors
Table 24. By Type, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Human Albumin Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Human Albumin Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Table 34. Octapharma Company Information, Head Office, Market Area, and Industry Position
Table 35. Octapharma Human Albumin Injection Models, Specifications, and Application
Table 36. Octapharma Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Octapharma Company Profile and Main Business
Table 38. Octapharma Recent Developments
Table 39. CSL Behring Company Information, Head Office, Market Area, and Industry Position
Table 40. CSL Behring Human Albumin Injection Models, Specifications, and Application
Table 41. CSL Behring Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. CSL Behring Company Profile and Main Business
Table 43. CSL Behring Recent Developments
Table 44. Biotest (UK) Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. Biotest (UK) Ltd Human Albumin Injection Models, Specifications, and Application
Table 46. Biotest (UK) Ltd Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Biotest (UK) Ltd Company Profile and Main Business
Table 48. Biotest (UK) Ltd Recent Developments
Table 49. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 50. Baxter Human Albumin Injection Models, Specifications, and Application
Table 51. Baxter Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Baxter Company Profile and Main Business
Table 53. Baxter Recent Developments
Table 54. Kedrion Biopharma, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 55. Kedrion Biopharma, Inc. Human Albumin Injection Models, Specifications, and Application
Table 56. Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Kedrion Biopharma, Inc. Company Profile and Main Business
Table 58. Kedrion Biopharma, Inc. Recent Developments
Table 59. Grifols Company Information, Head Office, Market Area, and Industry Position
Table 60. Grifols Human Albumin Injection Models, Specifications, and Application
Table 61. Grifols Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Grifols Company Profile and Main Business
Table 63. Grifols Recent Developments
Table 64. GE HealthCare Company Information, Head Office, Market Area, and Industry Position
Table 65. GE HealthCare Human Albumin Injection Models, Specifications, and Application
Table 66. GE HealthCare Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. GE HealthCare Company Profile and Main Business
Table 68. GE HealthCare Recent Developments
Table 69. Bio Products Laboratory Company Information, Head Office, Market Area, and Industry Position
Table 70. Bio Products Laboratory Human Albumin Injection Models, Specifications, and Application
Table 71. Bio Products Laboratory Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bio Products Laboratory Company Profile and Main Business
Table 73. Bio Products Laboratory Recent Developments
Table 74. Green Cross Company Information, Head Office, Market Area, and Industry Position
Table 75. Green Cross Human Albumin Injection Models, Specifications, and Application
Table 76. Green Cross Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Green Cross Company Profile and Main Business
Table 78. Green Cross Recent Developments
Table 79. SK Plasma Company Information, Head Office, Market Area, and Industry Position
Table 80. SK Plasma Human Albumin Injection Models, Specifications, and Application
Table 81. SK Plasma Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. SK Plasma Company Profile and Main Business
Table 83. SK Plasma Recent Developments
Table 84. Instituto Grifols Company Information, Head Office, Market Area, and Industry Position
Table 85. Instituto Grifols Human Albumin Injection Models, Specifications, and Application
Table 86. Instituto Grifols Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Instituto Grifols Company Profile and Main Business
Table 88. Instituto Grifols Recent Developments
Table 89. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 90. Takeda Human Albumin Injection Models, Specifications, and Application
Table 91. Takeda Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Takeda Company Profile and Main Business
Table 93. Takeda Recent Developments
Table 94. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 95. Hualan Bio Human Albumin Injection Models, Specifications, and Application
Table 96. Hualan Bio Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Hualan Bio Company Profile and Main Business
Table 98. Hualan Bio Recent Developments
Table 99. Nanyue Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 100. Nanyue Biopharmaceuticals Human Albumin Injection Models, Specifications, and Application
Table 101. Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Nanyue Biopharmaceuticals Company Profile and Main Business
Table 103. Nanyue Biopharmaceuticals Recent Developments
List of Figures
Figure 1. Human Albumin Injection Picture
Figure 2. Global Human Albumin Injection Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Human Albumin Injection Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Human Albumin Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Human Albumin Injection Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Human Albumin Injection Sales Quantity (K Units) & (2018-2029)
Figure 7. China Human Albumin Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Human Albumin Injection Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Human Albumin Injection Market Share of Global, 2018-2029
Figure 10. Global Human Albumin Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Human Albumin Injection Key Participants, Market Share, 2022
Figure 12. Global Human Albumin Injection Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Human Albumin Injection Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Human Albumin Injection Production Market Share & Forecast by Region, 2018-2029
Figure 15. Human Albumin Injection Industry Chain
Figure 16. Human Albumin Injection Procurement Model
Figure 17. Human Albumin Injection Sales Model
Figure 18. Human Albumin Injection Sales Channels, Direct Sales, and Distribution
Figure 19. Blood Extraction
Figure 20. Recombine
Figure 21. By Type, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Clinic
Figure 28. By Application, Global Human Albumin Injection Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Human Albumin Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Human Albumin Injection Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Human Albumin Injection Sales Quantity Market Share, 2018-2029
Figure 35. North America Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Human Albumin Injection Consumption Value Market Share, 2022
Figure 37. Europe Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Human Albumin Injection Consumption Value Market Share, 2022
Figure 39. Asia Pacific Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Human Albumin Injection Consumption Value Market Share, 2022
Figure 41. South America Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Human Albumin Injection Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Human Albumin Injection Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Human Albumin Injection Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Human Albumin Injection Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|